Arthur G. James Cancer Hospital

What Arthur G. James Cancer Hospital does

The Arthur G. James Cancer Hospital, operating under the brand OSUCCC – James, is a public academic cancer treatment and research center and the only NCI-designated Comprehensive Cancer Center in central Ohio. Founded in 1990, it is operated as part of The Ohio State University Wexner Medical Center in Columbus, Ohio, and serves a Midwest U.S. patient population with 1,001–5,000 staff across clinical and research functions. The institution integrates direct patient care with academic research, drawing on state appropriations, federal research grants (via NCI designation), patient service revenue, and philanthropic support.

The hospital's notable proprietary clinical offerings center on precision oncology. First, it has developed and clinically validated custom 3D-printed anatomical models for head and neck cancer surgery, with a 68-patient study showing complete tumor removal rates of 92% versus 74% without models. Second, it is advancing a blood-based diagnostic test for HPV-associated throat cancer to enable personalized treatment selection. Both products are embedded within direct clinical service delivery rather than sold as standalone commercial products.

OSUCCC – James does not operate a traditional commercial go-to-market motion. Patient services are billed through insurance, Medicare/Medicaid, and direct patient billing, while demand generation relies on physician referrals, community outreach, clinical trial recruitment, and academic publication. Revenue and pricing are not publicly disclosed at the entity level, as operations are consolidated within Ohio State University; pricing is therefore non-transparent and commercially idiosyncratic.

Name

Arthur G. James Cancer Hospital

Legal name

Arthur G. James Cancer Hospital

Website

https://cancer.osu.edu

Company type

Public

Founded year

1990

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

OSUCCC – James (Arthur G. James Cancer Hospital) is a public NCI-designated Comprehensive Cancer Center within Ohio State University Wexner Medical Center in Columbus, Ohio, providing precision oncology care and clinical research to Midwest cancer patients, including 3D-printed surgical models and personalized diagnostics.

Ownership category

akta.pro rank

Product category

Cancer Treatment and Research

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (62151), Offices of Physicians (62111)

SIC

Services-Health Services (8000), Services-Medical Laboratories (8071)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Head & Neck Surgery (ENT Oncology) (HLAKAMAF), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE)

Keywords

• Cancer treatment services
• Oncology research
• Surgical oncology
• Precision medicine
• Clinical trials

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Core offering

Arthur G. James Cancer Hospital (OSUCCC – James) is an NCI-designated Comprehensive Cancer Center within The Ohio State University Wexner Medical Center that delivers inpatient and outpatient cancer care, conducts translational oncology research, and offers access to clinical trials. It provides advanced diagnostic and treatment capabilities such as custom 3D-printed surgical models for head and neck tumor removal and blood-based testing to personalize therapy for HPV-associated throat cancer.

Product overview

Arthur G. James Cancer Hospital (OSUCCC – James) is a comprehensive cancer treatment and research center offering multiple clinical services including custom 3D-printed surgical models for head and neck cancer procedures and blood-based diagnostic testing for HPV-associated throat cancer. These products represent advanced precision medicine approaches integrated within a unified cancer care delivery platform.

Differentiator

Problem solved

Functional benefit

Products and services

• 3D-Printed Surgical Models for Head and Neck Cancer Custom 3D-printed anatomical models used in head and neck cancer surgeries to improve tumor removal precision, achieving a 92% complete tumor removal rate compared to 74% without models. Offered to surgical oncology patients requiring tumor resection.
• Blood-Based Test for HPV-Associated Throat Cancer A blood-based diagnostic test that enables personalized treatment planning and monitoring for patients with HPV-associated throat cancer. Used by oncologists to tailor therapy to individual patient biomarkers.

Quantifiable outcome

• 92% of cases achieved complete tumor removal using 3D-printed models compared to 74% without models

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Recent moves2 records

Expansion highlights3 records

Direct peers

• Memorial Sloan Kettering Cancer Center: Premier NCI-designated Comprehensive Cancer Center focused exclusively on cancer treatment and research. Directly comparable to OSUCCC – James as a specialty cancer hospital with strong surgical oncology programs and a leading clinical trials portfolio.
• Vanderbilt-Ingram Cancer Center: NCI-designated Comprehensive Cancer Center within Vanderbilt University Medical Center. Directly comparable as an academic specialty cancer hospital combining clinical oncology services with translational research and clinical trials.
• Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center within Mayo Clinic's academic medical system. Directly comparable as a destination specialty cancer hospital offering surgical, medical, and radiation oncology plus extensive clinical research infrastructure.
• Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center with strong research and bone marrow transplantation programs. Comparable as a specialty cancer center combining clinical care with leading translational research and clinical trials.
• MD Anderson Cancer Center: One of the original NCI-designated Comprehensive Cancer Centers and the leading U.S. academic cancer hospital. Directly comparable as a specialty oncology hospital offering surgical oncology, medical oncology, diagnostics, and clinical trials within a major university system.
• Johns Hopkins Sidney Kimmel Cancer Center: NCI-designated Comprehensive Cancer Center embedded within Johns Hopkins Medicine. Directly comparable as an academic specialty cancer hospital with leading programs in head and neck oncology, surgical oncology, and translational cancer diagnostics.
• Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard and Brigham and Women's. Directly comparable as an academic specialty oncology provider with a strong research and clinical trials portfolio spanning medical, surgical, and pediatric oncology.
• Roswell Park Comprehensive Cancer Center: One of the original NCI-designated Comprehensive Cancer Centers. Directly comparable as a freestanding specialty cancer hospital focused on surgical, medical, and radiation oncology with strong research and clinical trials programs.

Regional players

• Cleveland Clinic Taussig Cancer Center: NCI-designated cancer program within Cleveland Clinic's integrated academic health system. Comparable as an Ohio-based specialty oncology provider offering surgical, medical, and radiation oncology plus clinical trials in overlapping Midwestern geography.
• University of Michigan Rogel Cancer Center: NCI-designated Comprehensive Cancer Center at the University of Michigan. Closely comparable as a Midwest-based Big Ten academic specialty cancer hospital competing with OSUCCC – James for regional referrals and research funding.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/osuccc_james
• Facebookfacebook.com/osucccjames

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arthur G. James Cancer Hospital